1,5,7,11-tetrahydroxymethyl-6,12-bis(4-methoxyphenyl)-3,9-diphenyloxycarbonyl-3,9-diazapentacyclo[6.4.0.0^2,7.0^4,11.0^5,10]dodecane

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1,5,7,11-tetrahydroxymethyl-6,12-bis(4-methoxyphenyl)-3,9-diphenyloxycarbonyl-3,9-diazapentacyclo[6.4.0.0^2,7.0^4,11.0^5,10]dodecane
• 英文别名: 1,5,7,11-Tetrahydroxymethyl-6,12-(4-methoxyphenyl)-3,9-diphenyloxycarbonyl-3,9-diazahexacyclo[6.4.0.02.7.04.11.05.10]dodecane；diphenyl 1,5,7,11-tetrakis(hydroxymethyl)-6,12-bis(4-methoxyphenyl)-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane-3,9-dicarboxylate
• 化学式: C₄₂H₄₂N₂O₁₀
• 分子量: 734.803
• InChiKey: JNJJZAXKACBFFD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  54
• 可旋转键数：
  12
• 环数：
  10.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  159
• 氢给体数：
  4
• 氢受体数：
  10

反应信息

• 作为产物：
  描述：

  tetramethyl 6,12-bis(4-methoxyphenyl)-3,9-diphenyloxycarbonyl-3,9-diazapentacyclo[6.4.0.0^2,7.0^4,11.0^5,10]dodecane-1,5,7,11-tetracarboxylate 在 calcium borohydride 作用下， 以 四氢呋喃 为溶剂， 反应 672000.0h， 以88%的产率得到1,5,7,11-tetrahydroxymethyl-6,12-bis(4-methoxyphenyl)-3,9-diphenyloxycarbonyl-3,9-diazapentacyclo[6.4.0.0^2,7.0^4,11.0^5,10]dodecane
  参考文献：
  名称：

  Cage DimericN-Acyl- andN-Acyloxy-4-aryl-1,4-dihydropyridines as First Representatives of a Novel Class of HIV-1 Protease Inhibitors

  摘要：

  The synthesis of a series of novel cage dimeric N-acyl and N-acyl-oxy-3-aryl-1,4-dihydropyridines starting either from solid-state synthetic ester dimers or hom monomeric 4-aryl-1,4-dihydropyridines is presented. Their biological evaluation as novel HIV-1 protease inhibitors showed the most active compounds to be 5c and 5i with inhibitory activities of 52% (50 mu M) and 49% (25 mu M), respectively. Within each series of N-acyl- and N-acyloxy derivatives NCOBz and NBoc groups were found to be the best substituents. Although they exhibiting only moderate activities these cage dimers hold promise as a class of novel non-peptidic HIV-1 protease inhibitors.

  DOI：

  10.1002/(sici)1521-4184(199911)332:11<380::aid-ardp380>3.0.co;2-t